Balyasny Asset Management’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-505,295
| Closed | -$2.82M | – | 3368 |
|
|
2024
Q3 | $2.82M | Buy |
505,295
+436,108
| +630% | +$3.05M | ﹤0.01% | 1528 |
|
|
2024
Q2 | $583K | Buy |
69,187
+15,630
| +29% | +$167K | ﹤0.01% | 1997 |
|
|
2024
Q1 | $773K | Sell |
53,557
-602,297
| -92% | -$9.96M | ﹤0.01% | 1894 |
|
|
2023
Q4 | $14.1M | Sell |
655,854
-280,493
| -30% | -$5M | 0.03% | 733 |
|
|
2023
Q3 | $18M | Buy |
936,347
+291,152
| +45% | +$6.21M | 0.04% | 611 |
|
|
2023
Q2 | $16.4M | Buy |
645,195
+3,417
| +0.5% | +$98.7K | 0.04% | 599 |
|
|
2023
Q1 | $23.2M | Buy |
641,778
+236,734
| +58% | +$8.31M | 0.06% | 452 |
|
|
2022
Q4 | $16M | Sell |
405,044
-135,999
| -25% | -$5.66M | 0.04% | 563 |
|
|
2022
Q3 | $25.2M | Buy |
541,043
+4,951
| +0.9% | +$230K | 0.08% | 349 |
|
|
2022
Q2 | $23.5M | Buy |
536,092
+27,197
| +5% | +$1.5M | 0.08% | 368 |
|
|
2022
Q1 | $36.8M | Buy |
508,895
+100,918
| +25% | +$7.28M | 0.12% | 224 |
|
|
2021
Q4 | $33.1M | Buy |
407,977
+151,700
| +59% | +$15.2M | 0.11% | 239 |
|
|
2021
Q3 | $29.8M | Buy |
+256,277
| New | +$33.5M | 0.12% | 230 |
|
|
2021
Q2 | – | Sell |
-176,987
| Closed | -$24.7M | – | 2442 |
|
|
2021
Q1 | $24.7M | Sell |
176,987
-30,293
| -15% | -$4.94M | 0.12% | 220 |
|
|
2020
Q4 | $35.9M | Buy |
207,280
+69,540
| +50% | +$11.3M | 0.2% | 123 |
|
|
2020
Q3 | $19.2M | Sell |
137,740
-135,365
| -50% | -$18.1M | 0.14% | 200 |
|
|
2020
Q2 | $32.6M | Buy |
273,105
+148,324
| +119% | +$17.6M | 0.28% | 80 |
|
|
2020
Q1 | $12.5M | Sell |
124,781
-201,520
| -62% | -$24.2M | 0.15% | 197 |
|
|
2019
Q4 | $38.4M | Buy |
326,301
+309,516
| +1,844% | +$30.7M | 0.23% | 118 |
|
|
2019
Q3 | $1.44M | Sell |
16,785
-34,470
| -67% | -$2.61M | 0.01% | 764 |
|
|
2019
Q2 | $3.32M | Buy |
51,255
+40,160
| +362% | +$2.5M | 0.02% | 727 |
|
|
2019
Q1 | $694K | Sell |
11,095
-153,731
| -93% | -$7.23M | ﹤0.01% | 1116 |
|
|
2018
Q4 | $6.41M | Buy |
164,826
+117,516
| +248% | +$5.22M | 0.05% | 458 |
|
|
2018
Q3 | $2.7M | Buy |
47,310
+43,837
| +1,262% | +$2.74M | 0.01% | 896 |
|
|
2018
Q2 | $277K | Sell |
3,473
-1,959
| -36% | -$163K | ﹤0.01% | 1546 |
|
|
2018
Q1 | $471K | Buy |
+5,432
| New | +$439K | ﹤0.01% | 1464 |
|
|
2017
Q4 | – | Sell |
-94,444
| Closed | -$8.58M | – | 2376 |
|
|
2017
Q3 | $8.58M | Buy |
+94,444
| New | +$8.09M | 0.03% | 555 |
|
|
2017
Q2 | – | Sell |
-36,400
| Closed | -$2.92M | – | 1814 |
|
|
2017
Q1 | $3.41M | Sell |
36,400
-132,531
| -78% | -$12M | 0.02% | 788 |
|
|
2016
Q4 | $12.3M | Buy |
168,931
+138,931
| +463% | +$11.9M | 0.07% | 417 |
|
|
2016
Q3 | $3.13M | Sell |
30,000
-45,000
| -60% | -$4.06M | 0.02% | 574 |
|
|
2016
Q2 | $5.53M | Buy |
+75,000
| New | +$5.09M | 0.04% | 477 |
|
Other funds holding NVRO
ACH
AC
B
RSCM
SC
Balyasny Asset Management's NVRO Position: Q4 2024 in Review
Balyasny Asset Management sold out of NEVRO CORP. (NVRO) in Q4 2024, closing a stake of 505,295 shares — an estimated $2.82M sold.
Balyasny Asset Management first reported a position in NVRO in Q2 2016 and held it in 31 quarters. The position peaked at $38.4M in Q4 2019. 129 funds tracked by Wall St. Rank hold NVRO as of Q4 2024.
- Balyasny Asset Management reported no remaining NEVRO CORP. position as of Q4 2024 after selling out during the quarter.
- Balyasny Asset Management sold 505,295 NEVRO CORP. shares in Q4 2024, an estimated $2.82M.
- Balyasny Asset Management first reported a position in NEVRO CORP. in Q2 2016 and held it in 31 quarters.
- Balyasny Asset Management's NEVRO CORP. position peaked at $38.4M in Q4 2019.
- 129 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2024.
Based on Balyasny Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.